WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Eli Lilly and Company

LillyLilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

www.lilly.com

Eli Lilly and Company RSS Channel

Filters
List of articles in category Eli Lilly and Company
Title Published Date
Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions 13 July 2011
Synthes and Lilly Sign Development and Collaboration Agreement 14 June 2011
Lilly and Investor Group Form New Critical Care Company BioCritica 24 May 2011
Lilly and Medtronic Announce Drug-Device Collaboration for Parkinson's Disease 28 April 2011
NAFE Names Lilly to Top 50 Companies for Executive Women 16 March 2011
Lilly Marks Major Milestone for Mirror Portfolio 15 February 2011
Lilly CEO Calls for a 'Wave of Invention' to Reduce the Toll of Diabetes 03 November 2010
Lilly Halts Development of Semagacestat for Alzheimer's Disease 18 August 2010
Lilly Reports Strong Second-Quarter 2010 Results 28 July 2010
Lilly to Acquire Alnara Pharmaceuticals 08 July 2010
Lilly USA Updates Health Education Program to Help Patients with Depression Build Network of Support 31 March 2010
Lilly's Online, Interactive Health Education Program Receives Two Web Awards 11 February 2010
Lilly Reports Fourth-Quarter and Full-Year 2009 Results 01 February 2010
Lilly Sends Relief to Haiti Earthquake Victims 20 January 2010
Resource Guide About Key Issues Facing the Pharmaceutical Industry 03 December 2009
Lilly CEO Lechleiter Calls for Repair of the 'Engine of Biopharma Innovation' 02 November 2009
Expert Panel Offers Three-Step Plan to Guide People Toward Recovery of Depression 15 October 2009
The Lilly TB Drug Discovery Initiative Announces New Collaborator 30 September 2009
Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients 15 September 2009
Online Video Library Launched To Share Martha Beck's Experience Living with Fibromyalgia 09 September 2009
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next
  • End

Business & Industry

  • Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
  • Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
  • Bayer Consumer Health leaders propose new principles for science-led self-care
  • GSK signs agreement to support pandemic preparedness in Europe
  • Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design

Research & Development

  • Scientists create long-acting injectable drug delivery system for tuberculosis
  • Treating cancer by sticking cells in place
  • Vitamin K prevents cell death: a new function for a long-known molecule
  • Disparities in United States COVID-19 vaccine distribution
  • New needle-free nasal vaccine shows promise for COVID-19
  • Scientists develop new biomimetic formulation for treating glioblastoma
  • SARS-CoV-2 hijacks nanotubes between neurons to infect them

Conferences & Events

  • New approach to treatment of deadly kidney cancer
  • SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference

Regulatory Affairs

  • FDA approves first systemic treatment for alopecia areata
  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  1. You are here:  
  2. Home
  3. Eli Lilly and Company
  4. Lilly will supply an additional 150,000 doses of bebtelovimab to U.S. government

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.